Janux Therapeutics, Inc. JANX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Brad Canino | Guggenheim | 23.04 $ | 72 $ | 48.96 % | 03/09/2025 |
| Sean McCutcheon | Raymond James | 25.15 $ | 65 $ | 39.85 % | 11/07/2025 |
| Justin Zelin | BTIG | 40.18 $ | 100 $ | 59.82 % | 03/12/2024 |
| David Dai | UBS | 51.75 $ | 69 $ | 17.25 % | 24/10/2024 |
| Bradley Canino | Stifel Nicolaus | 43.71 $ | 70 $ | 26.29 % | 05/09/2024 |
| George Farmer | Scotiabank | 36.49 $ | 42 $ | 5.51 % | 09/08/2024 |
| George Farmer | Scotiabank | 47.6 $ | 47 $ | -0.60 % | 30/05/2024 |
| Swayampakula Ramakanth | H.C. Wainwright | 49.63 $ | 63 $ | 13.37 % | 13/05/2024 |
| Kaveri Pohlman | BTIG | 39.13 $ | 62 $ | 22.87 % | 20/03/2024 |